Congress Weighs Repeal of Tax Credit for Rare Disease Drugs By KATIE THOMAS and SHEILA KAPLAN from NYT Health http://ift.tt/2zpkko8 via IFTTT Tweet Postingan terkait: McKesson, Drug Distribution Giant, Settles Lawsuit Over Opioids in West VirginiaTop Executives of Insys, an Opioid Company, Found Guilty of RacketeeringTop Executives of Opioid Company Found Guilty of RacketeeringF.D.A. Won’t Ban Sales of Textured Breast Implants Linked to CancerTrump Administration Files Formal Request to Strike Down All of Obamacare
Belum ada tanggapan untuk "Congress Weighs Repeal of Tax Credit for Rare Disease Drugs"
Posting Komentar